Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)

Published:2021-05 Issue:3 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Eadie Ashley L.¹^ORCID,Brunt Keith R.¹,Herder Matthew²³

Affiliation:

1. Department of Pharmacology Faculty of Medicine Dalhousie University Saint John New Brunswick Canada

2. Department of Pharmacology Faculty of Medicine Dalhousie University Halifax Nova Scotia Canada

3. Health Law Institute Schulich School of Law Dalhousie University Halifax Nova Scotia Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.794

Reference81 articles.

1. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses

2. Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

3. Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

4. Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

5. Reporting of Studies on New Medicines in Major Medical Journals: A Case Study in Breast Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solubilization techniques used for poorly water-soluble drugs;Acta Pharmaceutica Sinica B;2024-09

2. Teaching an old drug new tricks: Regulatory insights for the repurposing of hemin in cardiovascular disease;Pharmacology Research & Perspectives;2024-06-24

3. Importance of Structural Databases, Molecular Pharmacophores, Supramolecular Heterosynthons, and Artificial Intelligence–Machine Learning–Neural Network Tools in Drug Discovery;Crystal Growth & Design;2024-05-30

4. The Safety and Efficacy of the Early Use of Sacubitril/Valsartan After Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials;Cureus;2024-02-07

5. Sacubitril/Valsartan in Heart Failure with Hypertension Patients: Real-World Experiences on Different Ages, Drug Doses, and Renal Functions;High Blood Pressure & Cardiovascular Prevention;2023-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3